Abdominal Neoplasms - 350 Studies Found
| Completed |
: Perioperative Systemic Therapy and Surgery Versus Surgery Alone for Resectable Colorectal Peritoneal Metastases. :
|
| Recruiting |
: Ruxolitinib Phosphate, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer :
: |
| Completed |
: Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors :
|
| Completed |
: Study of Mirvetuximab Soravtansine in Comb. With Bevacizumab, Carboplatin, PLD or Pembrolizumab in Adults With FRa + Adv. EOC, Primary Peritoneal, Fallopian Tube, or Endometrial Cancer :
|
| Completed |
: Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum :
: Drug: Nilotinib-adriamycin The nilotinib-adriamycin combination will be given in 4 cycles of 21 days. In |
| Completed |
: Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies :
|
| Completed |
: Safety and Efficacy of CRS-207 With Epacadostat in Platinum Resistant Ovarian, Fallopian or Peritoneal Cancer :
|
| Completed |
: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer :
|
| Completed |
: Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer :
|
| Completed |
: Study of Safety & Biological Activity of IP GEN-1 With Neoadjuvant Chemo in Ovarian Cancer :
|